Type 1 diabetes is an autoimmune condition in which the body’s immune system destroys insulin-producing cells in the pancreas, requiring lifelong insulin therapy. With the global number of cases projected to rise to as many as 17.4 million by 2040, our journals provide essential updates on breakthroughs in treatment and management for those living with type 1 diabetes.